drugset / Trial / NCT05914077

Aspiration of Duodenopancreatic Juice After Secretin Stimulation vs Endoscopic Aspiration for Molecular Analysis of Intraductal Papillary Mucinous Intraductal Neoplasia.

NCT05914077

Phase 3 Unknown 140 enrolled Fundacion Clinic per a la Recerca Biomédica
RandomizedCrossoverOpen-labelDiagnostic

Summary

Study to evaluate aspiration of duodenopancreatic juice after secretin stimulation (ADPJ-secr)versus endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) for molecular analysis of intraductal papillary mucinous intraductal neoplasia.

Timeline

Start
2023-09-13
Primary completion
2025-01
Completion
2025-01

Drugs

EvaluationDrugModalityDoseRoute
Background Secretin Other / unclassified 0.2 ug/kg Intravenous